Survivin Promotes Stem Cell Competence for Skin Cancer Initiation

Area of Science:

• Oncology
• Stem Cell Biology
• Dermatology

Background:

• Skin cancer arises from the dysregulation of normal cellular processes.
• Stem cells (SCs) and progenitor cells (Ps) have distinct roles in tissue homeostasis and disease.
• Understanding the molecular mechanisms driving skin cancer initiation is critical for developing targeted therapies.

Purpose of the Study:

• To identify key regulators differentiating the cancer-initiating potential of skin stem cells (SCs) versus progenitor cells (Ps).
• To elucidate the role of Survivin in the survival, self-renewal, and differentiation of oncogene-targeted SCs.
• To determine why SCs, but not Ps, can initiate skin cancer.

Main Methods:

• Analysis of Survivin expression in skin stem cells (SCs) and progenitor cells (Ps).
• Investigating the effects of Survivin modulation on SC survival, self-renewal, differentiation, and apoptosis.
• Utilizing models of oncogene-induced skin cancer to assess the role of Survivin in tumor initiation.

Main Results:

• Survivin was identified as a critical regulator in skin cancer initiation.
• Survivin expression in oncogene-targeted SCs is essential for their survival and self-renewal.
• Survivin prevents differentiation and apoptosis in SCs, enabling them to initiate skin cancer, a function not observed in Ps.

Conclusions:

• Survivin plays a pivotal role in conferring the cancer-initiating capacity to skin stem cells (SCs).
• Targeting Survivin may offer a strategy to inhibit skin cancer initiation by preventing SC survival and promoting their differentiation or apoptosis.
• The differential expression and function of Survivin in SCs versus Ps explain their distinct roles in skin tumorigenesis.